Table 2.
Small Artery Profile and Echocardiographic Examination of Patients With Metabolic Syndrome and Control Subjects
| Characteristics | Obese (n=17) | Controls (n=5) | P Value |
|---|---|---|---|
| Endothelial function | 86.74±11.60 | 98.70±4.31 | 0.08 |
| Endo l‐NMMA | 76.85±9.95 | 78.00±9.90 | 0.88 |
| CSA | 11 634.12±3454.51 | 9303.04±3122.23 | 0.54 |
| Wall:lumen ratio | 20.77±5.72 | 16.13±4.45 | 0.12 |
| Wall thickness | 24.79±5.06 | 19.90±4.79 | 0.07 |
| LV mass | 183.51±43.51 | 152.95±41.14 | 0.26 |
| LV mass/m2 | 88.42±22.26 | 83.51±15.22 | 0.75 |
| Mean LA volume | 52.81±16.77 | 52.84±11.27 | 0.94 |
| E:A ratio | 0.93±0.23 | 1.19±0.17 | 0.048 |
| Mean TDI E:A | 0.78±0.30 | 0.88±0.28 | 0.54 |
| Septal E:E′ | 11.16±3.72 | 9.63±2.67 | 0.49 |
| Lateral E:E′ | 8.90±4.17 | 5.73±1.68 | 0.16 |
Comparison of structural characteristics of small arteries from subcutaneous gluteal fat samples and echocardiographic assessment of diastolic parameters in patients with metabolic syndrome and healthy control participants. Values are mean±SD. CSA indicates cross‐sectional area; l‐NMMA, N G‐monomethyl‐l‐arginine; LA, left atrial; LV, left ventricle; TDI, tissue Dopper imaging.